Delivery Order SPE2DB22D3010-SPE2DB24FP1LN
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TASIGNA 150 MG CAPSULE 28S. The contract has a potential value of $11,249.24 and a performance period through March 25, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TASIGNA 150 MG CAPSULE 28S. The $16,873.86 award is for pharmaceutical products and has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is a prime contractor providing a range of pharmaceutical and medical supply products to DLA Troop Support Medical facilities. This delivery order was not set aside for any...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical to supply TASIGNA 150 MG CAPSULE 28S pharmaceutical products. The $11,249.24 order was awarded on December 1, 2023 and requires completion by December 22, 2023. Performance will take place at Amerisourcebergen's headquarters location in Conshohocken, Pennsylvania. No set-aside designation was applied to this order....
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a $5,624.62 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide TASIGNA 150 MG CAPSULE 28S, with a completion date of February 15, 2024. This award is part of a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as Amerisourcebergen's primary contract to deliver pharmaceuticals and medical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TASIGNA 150 MG CAPSULE 28S. The $5,624.62 award has a completion date of February 12, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to support Department of Defense...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a potential value of $5,624.62. The contract has a completion date of March 14, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract with DLA, which has a potential value of...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,007.90 firm fixed-price delivery order is for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 28, 2025. There is no set-aside designation associated with this award. AmerisourceBergen holds a $999,999,999...
- This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TASIGNA 200 MG CAPSULE 28S. The contract has a potential value of $11,249.24 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for delivering...
- Amerisourcebergen Drug Corporation, under its parent company Amerisourcebergen Corporation, has been awarded a $11,249.24 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4562356862 TASIGNA 150 MG CAPSULE 28S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility and the period of performance is September 29, 2023 through October 23, 2023. No subcontractors or set aside designations were indicated....
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP1LNDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TASIGNA 150 MG CAPSULE 28S pharmaceutical products. The $5,624.62 contract has a completion date of February 12, 2024 and was awarded on January 22, 2024. No set-aside designations were used. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and related distribution services to support DLA Troop Support Medical programs and facilities. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 1/22/24 |